Italia markets open in 6 hours 37 minutes

SIGA Technologies, Inc. (SIGA)

NasdaqGM - NasdaqGM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
8,23-0,28 (-3,29%)
Alla chiusura: 04:00PM EDT
8,33 +0,10 (+1,20%)
Dopo ore: 07:40PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente8,51
Aperto8,40
Denaro8,22 x 200
Lettera8,25 x 200
Min-Max giorno8,18 - 8,53
Intervallo di 52 settimane4,22 - 10,00
Volume714.178
Media Volume774.193
Capitalizzazione585,084M
Beta (5 anni mensile)0,97
Rapporto PE (ttm)8,66
EPS (ttm)0,95
Prossima data utili29 feb 2024 - 04 mar 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendo25 mar 2024
Stima target 1AN/D
  • GlobeNewswire

    SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer

    NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Jay K. Varma has joined SIGA as Executive Vice President and Chief Medical Officer (CMO). He will also continue to serve as a director of the SIGA Board of Directors. “As SIGA has worked to support the global response to the MPOX outbreak and as we continue to expand our role in planning for the preve

  • GlobeNewswire

    SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023

    - In July, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and six months ended June 30, 2023. “SIGA’s second quarter financial results reflect the continuation of international sales activity that

  • GlobeNewswire

    SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®

    Exercise of Procurement Options of Approximately $113 Million for Oral TPOXX and Approximately $25 Million for IV TPOXX under Current Contract reflects continuing global action to enhance smallpox preparednessNEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human Services exercised procurement options for the delivery of approximately $113 million worth of o